Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: Involvement of bone marrow stromal cells

Clinical and Experimental Immunology

Volumn 152, Issue 1, 2008, Pages 153-162

  Miyake, T ^a   Inaba, M ^a   Fukui, J ^a   Ueda, Y ^a   Hosaka, N ^a   Kamiyama, Y ^a   Ikehara, S ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow stromal cells; Donor lymphocyte infusion; Graft versus host disease; Intrabone marrow bone marrow transplantation

Indexed keywords

CYTOKINE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL 6 MOUSE; CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DONOR; DONOR LYMPHOCYTE INFUSION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INJECTION; IRRADIATION; LEUKOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STATISTICAL SIGNIFICANCE; STROMA CELL; T LYMPHOCYTE; THERAPY EFFECT;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; GRAFT VS HOST DISEASE; HEPATOCYTE GROWTH FACTOR; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-3; LYMPHOCYTE TRANSFUSION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; STROMAL CELLS; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA;

EID: 40449120655     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03615.x     Document Type: Article

References (32)

1. Ikehara S. Bone marrow transplantation: a new strategy for intractable disease. Drugs Today 2002 38 : 103 11.
2. Ikehara S, Ohtsuki H, Good RA et al. Prevention of type I diabetes in non-obese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 1985 22 : 7743 7.
3. Yasumizu R, Sugiura K, Iwai H et al. Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue. Proc Natl Acad Sci USA 1987 84 : 6555 7.
4. Than S, Ishida H, Inaba M et al. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp Med 1992 176 : 1233 8.
5. Ishida T, Inaba M, Hisha H et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994 152 : 3119 27.
6. Nakagawa T, Nagata N, Hosaka N, Ogawa R, Nakamura K, Ikehara S. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells). Arthritis Rheum 1993 36 : 263 8.
7. Kushida T, Inaba M, Hisha H et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001 97 : 3292 9.
8. Taira M, Inaba M, Takata K et al. Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells. Transplantation 2005 79 : 680 7.
9. Nakamura K, Inaba M, Sugiura K et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of graft-versus-host diseases (GvHD) by intra-bone marrow-bone marrow transplantation plus donor lymphocyte infusion. Stem Cells 2004 22 : 125 34.
10. Hashimoto F, Sugiura K, Inoue K, Ikehara S. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997 89 : 49 54.
11. Sugiura K, Hisha H, Ishikawa J et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro. Stem Cells 2001 19 : 46 58.
12. Ikehara S. A novel strategy for allogeneic stem cell transplantation: perfusion method plus intra-bone marrow injection of stem cells. Exp Hematol 2003 31 : 1142 6.
13. Fukui J, Inaba M, Ueda Y et al. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells. Stem Cells 2007 25 : 1595 601.
14. Golde DW, Gasson JC. Hormones that stimulate the growth of blood cells. Sci Am 1988 259 : 62 71.
15. Gordon MY. Extracellular matrix of the marrow microenvironment. Br J Haematol 1988 70 : 1 4.
16. Dexter TM. Regulation of hemopoietic cell growth and development: experimental and clinical studies. Leukemia 1989 3 : 469 74.
17. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000 9 : 841 8.
18. Muriel S, Francoise N, Aurelie T et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 2006 176 : 7761 7.
19. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99 : 3838 43.
20. Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003 101 : 3722 9.
21. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates. Blood 2003 101 : 2999 3001.
22. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995 16 : 557 64.
23. Sudeepta A, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105 : 1815 22.
24. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003 75 : 389 97.
25. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003 5 : 485 9.
26. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003 57 : 11 20.
27. Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 2003 171 : 3426 34.
28. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 102 : 3837 44.
29. Beyth S, Borovsky Z, Mevorach D et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005 105 : 2214 9.
30. Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004 103 : 4619 21.
31. Augello A, Tasso R, Negrini SM et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 2005 35 : 1482 90.
32. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002 30 : 42 8.